No other details were disclosed. The announcement was made after trading hours on Tuesday, 2 February 2010.

Meanwhile, the BSE Sensex was up 303.87 points, or 1.88%, to 16467.31.

On BSE, 3301 shares were traded in the counter as against an average daily volume of 11,804 shares in the past one quarter.

The stock hit a high of Rs 162.45 and a low of Rs 155.60 so far during the day. The stock had hit a 52-week high of Rs 195 on 7 January 2010 and a 52-week low of Rs 51 on 9 March 2009.

The stock had underperformed the market over the past one month till 2 February 2010, falling 0.56% compared with the Sensex's 7.45% fall. It outperformed the market in past one quarter, rising 22.84% as against 1.68% rise in the Sensex.

The small-cap speciality chemical maker has an equity capital of Rs 6.48 crore. Face value per share is Rs 10.

The current price of Rs 157.37 discounts the company's Q3 December 2009 annualised EPS of Rs 25.99, by a PE multiple of 6.05.

Balaji Amines' net profit rose 46.7% to Rs 4.21 crore on a 25.1% rise in sales to Rs 63.67 crore in Q3 December 2009 over Q3 December 2008.

Balaji Amines manufactures methylamines, ethylamines, and derivatives of specialty chemicals and natural products. The company supplies its products to companies in the pharmaceutical and pesticide industries in India and elsewhere throughout the world.

Promoters have pledged 12.86 lakh shares, or 19.85% of the equity capital of the company. The total promoter shareholding in the company is 54.94% (end December 2009).